Summary:
- This article discusses the potential of using gene editing techniques, such as CRISPR-Cas9, to treat rare genetic diseases. It highlights the progress made in the field and the challenges that still need to be addressed.
- The article explores the use of gene editing to correct genetic defects and potentially cure diseases like sickle cell disease, Duchenne muscular dystrophy, and cystic fibrosis, among others.
- It discusses the regulatory and ethical considerations surrounding the use of gene editing in human therapies, as well as the need for continued research and development to improve the safety and efficacy of these techniques.